Drug delivery methods targeting the lymphatic system
AssigneeSorrento Therapeutics, Inc.
InventorRUSSELL FREDERICK ROSS
Life of this patent
Estimating the term…
Loading patent…
AssigneeSorrento Therapeutics, Inc.
InventorRUSSELL FREDERICK ROSS
Estimating the term…
Disclosed herein is a method for administering a therapeutic agent to multiple regions of the lymphatic system of a patient. The method generally includes placing two medical devices comprising a plurality of microneedles on the skin of the patient at two different locations proximate lymph vessels and/or lymph capillaries that drain into the right lymphatic duct and the thoracic duct; inserting the plurality of microneedles of medical devices into the patient to a depth whereby at least the epidermis is penetrated and administering via the microneedles of the medical devices a therapeutic agent into the lymphatic system of the patient. Disclosed herein also is a method for preventing or reducing cancer metastasis in a patient. Disclosed herein also is a method for treating an inflammatory medical condition in a patient.
A method for administering a therapeutic agent to the lymphatic system of a patient, the method comprising:
A method for administering a therapeutic agent to the lymphatic system of a patient, the method comprising:
A method for preventing or reducing cancer metastasis in a patient, the method comprising:
A method for preventing or reducing cancer metastasis in a patient, the method comprising:
A method of treating cancer in a patient, comprising:
A method for treating an inflammatory medical condition in a patient, the method comprising:
A method for lowering the TNF-α level in a patient, the method comprising:
A method for treating an inflammatory medical condition in a patient, the method comprising:
A method for treating an inflammatory medical condition in a patient, the method comprising:
Dependencies are inferred from the claim text.